SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-07-002843
Filing Date
2007-02-05
Accepted
2007-02-05 20:22:13
Documents
2
Period of Report
2007-02-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 9592
2 POWER OF ATTORNEY ex24poakgollust.txt EX-24 3679
  Complete submission text file 0001179110-07-002843.txt   14918
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Issuer) CIK: 0001157601 (see all company filings)

IRS No.: 000000000
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SYNTA PHARMACEUTICALS CORP. 45 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 781-274-8200
Gollust Keith R (Reporting) CIK: 0001325712 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33277 | Film No.: 07582278